Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New endothelin antagonists from RPR reported at 211th ACS

April 5, 1996

New agent for sudden cardiac death in phase I at Nortran

April 5, 1996

Another antioxidant from Oxis: TX-153

April 5, 1996

BXT-51072 in line for clinical evaluation at Oxis

April 5, 1996

Novel vasoprotectants in AtheroGenics' pipeline

April 5, 1996

PB-005 slated to enter phase II

April 5, 1996

Genentech claims vitronectin antagonists

April 5, 1996

Vitronectin receptor antagonist revealed by SmithKline Beecham

April 5, 1996

New PAF antagonist discovered at Abbott

April 5, 1996

Zeneca selects NMDA antagonist for preclinical study

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...